ABCL
Abcellera Biologics Inc
13.70$
-1.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | -24.4% | +742.2% | +977.9% | +13.4% | -115.8% | – | – | |
| – | +101.2% | +185.4% | +227.3% | +91.9% | -6.7% | +214.0% | -77.1% | |
| – | +44.7% | +843.5% | +265.0% | +61.5% | +29.7% | +5.3% | -17.4% | |
| – | +153.5% | +1,301.8% | +111.8% | +73.7% | – | – | – | |
| – | +3.3% | -6,011.9% | – | -28.4% | -55.7% | -295.4% | – | |
| – | -24.7% | +267.1% | +298.4% | +24.3% | +6.7% | +1.1% | -45.4% | |
| – | +8.9% | +1,972.3% | +177.4% | +6.1% | -37.3% | – | -27.7% | |
| – | – | – | – | – | – | – | – | |
| – | – | -100.0% | – | – | – | – | – | |
| – | -90.9% | +47,032.0% | -101.1% | -66.0% | – | – | – | |
| – | -98.4% | +350,491.3% | -100.6% | -58.1% | – | +23.3% | +10.3% | |
| – | -127.7% | – | -115.9% | – | – | – | -223.3% | |
| – | – | – | +2,221.7% | +10.0% | -159.3% | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.